- Home
- ARTL vs GITS Comparison
ARTL vs GITS Comparison
Compare ARTL & GITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTL
- GITS
- Stock Information
- Founded
- ARTL 2011
- GITS 2018
- Country
- ARTL United States
- GITS South Korea
- Employees
- ARTL N/A
- GITS N/A
- Industry
- ARTL Biotechnology: Pharmaceutical Preparations
- GITS
- Sector
- ARTL Health Care
- GITS
- Exchange
- ARTL Nasdaq
- GITS Nasdaq
- Market Cap
- ARTL 7.0M
- GITS 7.0M
- IPO Year
- ARTL N/A
- GITS N/A
- Fundamental
- Price
- ARTL $5.47
- GITS $2.63
- Analyst Decision
- ARTL Buy
- GITS
- Analyst Count
- ARTL 2
- GITS 0
- Target Price
- ARTL $30.00
- GITS N/A
- AVG Volume (30 Days)
- ARTL 120.0K
- GITS 23.0K
- Earning Date
- ARTL 11-11-2025
- GITS 08-15-2025
- Dividend Yield
- ARTL N/A
- GITS N/A
- EPS Growth
- ARTL N/A
- GITS N/A
- EPS
- ARTL N/A
- GITS N/A
- Revenue
- ARTL N/A
- GITS $29.00
- Revenue This Year
- ARTL N/A
- GITS N/A
- Revenue Next Year
- ARTL N/A
- GITS N/A
- P/E Ratio
- ARTL N/A
- GITS N/A
- Revenue Growth
- ARTL N/A
- GITS N/A
- 52 Week Low
- ARTL $4.20
- GITS $0.87
- 52 Week High
- ARTL $28.60
- GITS $9.78
- Technical
- Relative Strength Index (RSI)
- ARTL 33.32
- GITS 59.18
- Support Level
- ARTL $4.60
- GITS $2.34
- Resistance Level
- ARTL $5.75
- GITS $2.74
- Average True Range (ATR)
- ARTL 0.52
- GITS 0.18
- MACD
- ARTL -0.07
- GITS 0.04
- Stochastic Oscillator
- ARTL 24.52
- GITS 84.36
About ARTL Artelo Biosciences Inc.
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
About GITS Global Interactive Technologies Inc. Common Stock
Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.